Abstract
Inflammation is a fundamental component of the body’s response to trauma and the invasion of foreign material. Although inflammation can occur in all tissues, as the structure of tissue at various sites differs, the response of the tissues are not necessarily the same. It is the purpose of this chapter to review the spectrum of mediators released during human allergic reactions in general, and in three specific target sites for the reaction, i.e. the skin, nose and airway. The effect of the mediators on the target tissues and the evidence for the relative importance for each mediator, or group of mediators, in the production of the reaction at each specific site is also discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Holgate, S. T. and Kay, A. B. (1985). Mast cells, mediators and asthma. Clin. Allergy, 15, 221–34
Takemura, R. and Werb, Z. (1984). Secretory products of macrophages and their physiological functions. Am. J. Physiol., 246 (Cell Physiol.), C1–C9
Holtzman, M. J., Aizawa, H., Nadel, J. A. and Goetzl, E. J. (1983). Selective generation of leukotriene B4 by tracheal epithelial cells from dogs. Biochem. Biophys. Res. Commun., 114, 1071–6
Gorman, R. R., Oglesby, T. D., Bundy, G. L. and Hopkins, N. K. (1985). Evidence for 15-HETE synthesis by human umbilical vein endothelial cells. Circulation, 72, 708–12
Barnes, P. J. (1986). Neural control of human airways in health and disease. Am. Rev. Resp. Dis., 134, 1289–314
Shore, S. A., Powell, W. S. and Martin, J. G. (1985). Endogenous prostaglandins modulate histamine-induced contraction in canine tracheal smooth muscle. J. Appl. Physiol., 58, 859–68
Regoli, D. and Barabe, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1–46
Lewis, T. (1927). The Blood Vessels of the Human Skin and their Responses. (London: Shaw and Sons)
Janeso, N., Jancso-Gabor, A. and Szolcsanyi, J. (1968). The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br. J. Pharmacol. Chemother., 32, 32–41
Fowler, II, J. W. and Louvel, F. C. (1966). The accumulation of eosinophils as an allergic response to allergen applied to the denuded skin surface. J. Allergy Clin. Immunol., 37, 19–28
Konno, A., Togawa, K. and Fujiwara, T. (1983). The mechanisms involved in onset of allergic manifestations in the nose. Eur. J. Resp. Dis., 64, 155–66
Richardson, P. S. and Phipps, R. J. (1978). The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease. Pharmacol. Ther. B., 3, 441–79
Marin, M. G. (1986). Pharmacology of airway secretion. Pharmacol. Rev., 38, 273–89
Laitinen, L. A., Heino, M., Laitinen, A., Kava, T. and Haahtela, T. (1985). Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Resp. Dis., 131, 599–606
Morgan, D. J. R., Moodley, I., Phillips, M. J. and Davies, R. J. (1983). Plasma histamine in asthmatic and control subjects following exercise: influence of circulating basophils and different assay techniques. Thorax, 38, 771–7
Foreman, J. C., Jordan, C. C., Oehme, P. and Renner, H. (1983). Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J. Physiol., 335, 449–65
Morley, J., Page, C. P., Mazzoni, L. and Sanjar, S. (1985). Anti-allergic drugs in asthma. Triangle, 24, 59–70
Fuller, R. W., Maltby, N., Richmond, R., Dollery, C. T., Taylor, G. W., Ritter, J. R. and Philipp, E. (1987). Oral nafazatrom in man: effect on inhaled antigen challenge. Br. J. Clin. Pharmacol., 23, 677–81
Heavey, D. J., Richmond, R., Turner, N. C., Kobza-Black, A., Taylor, G. W., Chappell, C. G., Barrow, S. E. and Dollery, C. T. (1986). Measurement of leukotrienes C4 and D4 in inflammatory fluids. In Piper, P. J. (ed.) The Leukotrienes: Their Biological Significance, pp. 185–98. (NY: Raven Press)
Dorsch, W., Ring, J., Reimann, H. J. and Geiger, R. (1982). Mediator studies in skin blister fluid from patients with dual skin reactions after intradermal allergen injection. J. Allergy Clin. Immunol., 70, 236–42
Heavey, D. J., Ind, P. W., Miyatake, A., Brown, M. J., MacDermot, J. and Dollery, C. T. (1984). Histamine released locally after intradermal antigen challenge in man. Br. J. Clin. Pharmacol., 18, 915–19
Heavey, D. J., Kobza-Black, A., Barrow, S. E., Chappell, C. G., Greaves, M. W. and Dollery, C. T. (1986). Prostaglandin D2 and histamine release in cold urticaria. J. Allergy Clin. Immunol., 78, 458–61
Dalsgaard, C.-J., Jonsson, C.-E., Hökfelt, T. and Cuello, A. C. (1983). Localization of substance P-immunoreactive nerve fibers in the human digital skin. Experientia, 39, 1018–20
Anand, P., Bloom, S. R. and McGregor, G. P. (1983). Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin. Br. J. Pharmacol., 67, 665–9
Proud, D., Togias, A., Naclerio, R. M., Crush, S. A., Normal, P. S. and Lichtenstein, L. M. (1983). Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J. Clin. Invest., 72, 1678–85
Naclerio, R. M., Proud, D., Peters, S. P., Silber, G., Kagey-Somotka, A., Adkinson, N. F., Jr. and Lichtenstein, L. M. (1986). Inflammatory mediators in nasal secretions during induced rhinitis. Clin. Allergy, 16, 101–10
Creticos, P. S., Peters, S. P., Franklin Adkinson, N., Jr., Naclerio, R. M., Hayes, E. C., Normal, P.S. and Lichtenstein, L. M. (1984). Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N. Engl. J. Med., 310, 1626–30
Shaw, R. J., Fitzharris, P., Wardlaw, A. J., Cromwell, O. and Kay, A. B. Leukotrienes and the upper airways. In Kay, A. B. (ed.) Asthma. Clinical Pharmacology and Therapeutic Progress, pp. 205–12. (Oxford: Blackwell Scientific Publications)
Zakrzewski, J. T., Barnes, N. C., Piper, P. J. and Costello, J. F. (1985). Measurement of leukotrienes in arterial and venous blood from normal and asthmatic subjects by radioimmunoassay. Br. J. Clin. Pharmacol., 19, 574P
Nakamura, T., Morita, Y., Kuriyama, M., Ishihara, K., Ito, K. and Miyamato, T. (1987). Platelet-activating factor in late asthmatic response. Int. Arch. Allergy Appl. Immun., 82, 57–61
Cundell, D. R., Morgan, D. J. R. and Davies, R. J. (1984). NCF — A mast cell specific chemotactic factor? Clin. Sci., 66, 50P
Cundell, D. R., Morgan, D. J. R. and Davies, R. J. (1985). NCA — Neutrophil chemoattractant activity released by lymphocytes. Clin. Sci., 68, 53P–54P
De Monchy, J. G. R., Keyzer, J. J., Kauffman, H. F., Beaumont, F. and De Vries, K. (1985). Histamine in late asthmatic reactions following house-dust mite inhalation. Agents Actions, 16, 252–5
De Monchy, J. G. R., Kauffman, H. F., Venge, P., Koëter, G. H., Jansen, H. M., Sluiter, H. J. and De Vries, K. (1985). Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Resp. Dis., 131, 373–6
Tonnel, A. B., Joseph, M., Gosset, P. H., Fournier, E. and Capron, A. (1983). Stimulation of alveolar macrophages in asthmatic patients after local provocation test. Lancet, 1, 1406–8
Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J., II, Gosset, P., Workman, R., Capron, A. and Oates, J. A. (1986). Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med., 315, 800–4
Christiansen, S. C., Proud, D. and Cochrane, C. G. (1987). Detection of tissue kallikrein in bronchoalveolar lavage fluid of asthmatic subjects. J. Clin. Invest., 79, 188–97
Turnbull, L. S., Turnbull, L. W., Leitch, A. G. and Crofton, J. W. (1977). Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet, 2, 526–9
Cromwell, O., Walport, M. J., Morris, H. R., Taylor, G. W., Hodson, M. E., Batten, J. and Kay, A. B. (1981). Identification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet, 2, 164–5
Barnes, P. J., Crossman, D. C. and Fuller, R. W. (1987). Cutaneous effects of neuropeptides are dependent upon both histamine and cyclooxygenase products. Br. J. Pharmacol., 90, 100P
Soter, N. A., Lewis, R. A., Corey, E. J. and Austen, K. F. (1983). Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J. Invest. Dermatol., 80, 115–19
Basran, G. S., Page, C. P., Paul, W. and Morley, J. (1983). Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? Eur. J. Pharmacol., 86, 143–4
Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R. and MacIntyre, I. (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature, 313, 54–6
Crossman, D. and Fuller, R. W. (1987). Effect of terfenidine and aspirin on bradykinin-induced wheals. Clin. Sci., 72, 75P
Barnes, P. J., Brown, M. J., Dollery, C. T., Fuller, R. W., Heavey, D. J. and Ind, P. W. (1986). Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br. J. Pharmacol., 88, 741–5
Basran, G. S., Morley, J., Paul, W. and Turner-Warwick, M. (1982). Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet, 1, 935–7
Barnes, V. F. and Heavey, D. J. (1986). Effect of prostaglandin D2 on histamine-induced weals in human skin. Br. J. Pharmacol., 87, 357–60
Heavey, D. J., Barnes, V. F., Orwin, J. and Brown, M. J. (1985). Inhibition of 5-HT induced axon reflex flares by MDL 72422. Br. J. Clin. Pharmacol., 21, 558P
Fuller, R. W., Warren, J. B., McCusker, M. and Dollery, C. T. (1987). Effect of enalapril on the skin response to bradykinin in man. Br. J. Clin. Pharmacol., 23, 88–90
Henocq, E. and Vargaftig, B. B. (1986). Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet, 1, 1378–9
Wihl, J.-A. (1983). Methods for assessing nasal reactivity. Eur. J. Resp. Dis., 64, 175–9
Karlsson, G., Pipkorn, V. and Andreasson, L. (1986). Substance P and human nasal mucociliary activity. Eur. J. Clin. Pharmacol., 30, 355–7
Collier, J. G. and Fuller, R. W. (1984). Capsaicin inhalation in man and the effects of sodium cromoglycate. Br. J. Pharmacol., 81, 113–17
Smith, L. J., Greenberger, P. A., Patterson, R., Krell, R. D. and Bernstein, P. R. (1985). The effect of inhaled leukotriene D4 in humans. Am. Rev. Resp. Dis., 131, 368–72
Hardy, C. C., Robinson, C., Tattersfield, A. E. and Holgate, S. T. (1984). The broncho-constrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N. Engl. J. Med., 311, 209–13
Fuller, R. W., Dixon, C. M. S., Cuss, F. M. and Barnes, P. J. (1987). Bradykinin-induced bronchoconstriction in humans. Mode of action. Am. Rev. Resp. Dis., 135, 176–80
Mathe, A. A. and Hedqvist, P. (1975). Effect of prostaglandins F2α and E2 on airway conductance in healthy subjects and asthmatic patients. Am. Rev. Resp. Dis., 111, 313–20
Costello, J. F., Dunlop, L. S. and Gardiner, P. J. (1985). Characteristics of prostaglandin induced cough in man. Br. J. Clin. Pharmac., 20, 355–9
Cuss, F. M., Dixon, C. M. S. and Barnes, P. J. (1986). Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet, 2, 189–92
Bisgaard, H. and Groth, S. (1987). Bronchial effects of leukotriene D4 inhalation in normal human lung. Clin. Sci., 72, 585–92
Manning, P. J., Jones, G. L. and O’Byrne, P. M. (1987). Indomethacin prevents histamine tachyphylaxis in asthmatics. Am. Rev. Resp. Dis., 135, A313
Fuller, R. W., Maxwell, D. L., Dixon, C. M. S., McGregor, G. P., Barnes, V. F., Bloom, S. R. and Barnes, P. J. (1987). Effect of substance P on cardiovascular and respiratory function in subjects. J. Appl. Physiol., 62, 1473–9
Walters, E. H., Parrish, R. W., Bevan, C. and Smith, A. P. (1981). Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax, 36, 571–4
Fuller, R. W., Dixon, C. M. S., Dollery, C. T. and Barnes, P. J. (1986). Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am. Rev. Resp. Dis., 133, 252–4
Barnes, N. C., Piper, P. J. and Costello, J. F. (1984). Actions of inhaled leukotrienes and their interactions with other allergic mediators. Prostaglandins, 28, 629–31
Pavia, D., Bateman, J. R. M., Sheahan, N. F., Agnew, J. E., Newman, S. P. and Clarke, S. W. (1980). Techniques for measuring lung mucociliary clearance. Eur. J. Resp. Dis., 61 (Suppl. 110), 157–68
Mezey, R. J., Cohn, M. A., Fernandez, R. J., Janusziewicz, A. J. and Wanner, A. (1978). Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am. Rev. Resp. Dis., 118, 677–84
Wanner, A. (1985). Mucociliary and mucus secretory function. Am. Rev. Resp. Dis., 131, S36–S38
Ahmed, T., Greenblatt, D. W., Birch, S., Marchette, B. and Wanner, A. (1980). Mucociliary transport in allergic patients with antigen-induced bronchospasm: role of slow reacting substance of anaphylaxis (SRS-A). Am. Rev. Resp. Dis., 121, A106
Wanner, A., Maurer, D., Abraham, W. M., Szepfalusi, Z. and Sielczak, M. (1983). Effects of chemical mediators of anaphylaxis on ciliary function. J. Allergy Clin. Immunol., 72, 663–7
Pavia, D., Sutton, P. P., Lopez-Vidriero, M. T., Agnew, J. E. and Clarke, S. W. (1983). Drug effects on mucociliary function. Eur. J. Resp. Dis., 64, 304–17
Braude, S., Royston, D., Coe, C. and Barnes, P. J. (1984). Histamine increases lung permeability by an H2-receptor mechanism. Lancet, 2, 372–4
Galant, S. P., Bullock, J., Wong, D. and Maibach, H. I. (1973). The inhibitory effect of antiallergy drugs on allergen and histamine induced wheal and flare response. J. Allergy Clin. Immunol., 51, 11–21
Krause, L. B. and Shuster, S. (1984). H2-receptor-active histamine not sole cause of chronic idiopathic urticaria. Lancet, 2, 929–30
Farr, P. M. and Diffey, B. L. (1985). A quantitative study of the effects of topical indomethacin on cutaneous erythema induced by ultraviolet radiation (UVR). Br. J. Dermatol., 113, 771–2
Warren, J. B., Pixley, F. J., Fuller, R. W. and Dollery, C. T. (1987). Effect of enalapril and terfenadine on skin antigen challenge. Clin. Sci., 73, 8P
Mygind, N., Secher, C. and Kirkegaard, J. (1983). Role of histamine and antihistamines in the nose. Eur. J. Resp. Dis., 64, 16–20
Mygind, N. and Borum, P. (1983). Effect of a cholino-ceptor antagonist in the nose. Eur. J. Resp. Dis., 64, 167–74
Proud, D., Kagey-Sobotka, A., Naclerio, R. M. and Lichtenstein, L. M. (1987). Pharmacology of upper airways challenge. Int. Arch. Allergy Appl. Immun., 82, 493–7
Mygind, N., Hansen, I. B. and Jørgensen, M. B. (1972). Disodium cromoglycate nasal spray in adult patients with perennial rhinitis. Acta Allergologica, 27, 372–80
Holgate, S. T., Twentyman, O. P., Rafferty, P., Beasley, R., Hutson, P. A., Robinson, C. and Church, M. K. (1987). Primary and secondary effector cells in the pathogenesis of bronchial asthma. Int. Arch. Allergy Appl. Immun., 82, 498–506
Britton, J., Hanley, S. P. and Tattersfield, A. E. (1987). The effect of an orally active leukotriene D4 (LTD4) antagonist L-649, 923 on the airway response to inhaled antigen in asthma. Thorax, 42, 219–20
Booij-Noord, H., Quanjer, H. and de Vries, K. (1971). Protektive Wirkung von Berotec bei Provokationstesten mit spezifischer Allergeninhalation und Histamin. Int. J. Clin. Pharmacol. Ther. Toxicol., 4, 69–72
Fairfax, A. J. and Morley, J. (1981). NSAIDs inhibit the late asthmatic response to antigen challenge. Br. J. Pharmacol., 74, 984P–985P
Braquet, P., Etienne, A., Touvay, C., Bourgain, R. H., Lefort, J. and Vargaftig, B. B. (1985). Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. Lancet, 1, 1501
Fujimura, M., Sasaki, F., Nakatsumi, Y., Takahashi, Y., Hifumi, S., Taga, K., Mifune, J.-I., Tanaka, T. and Matsuda, T. (1986). Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax, 41, 955–9
Kirby, F. E., Hargreave, P. M. and O’Byrne, P. M. (1987). Indomethacin inhibits allergen-induced airway hyperresponsiveness but not allergen-induced asthmatic responses. Am. Rev. Resp. Dis., 135, A312
Dahl, R. and Johansson, S.-A. (1982). Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur. J. Resp. Dis., 63 (Suppl. 122), 167–75
Dixon, C. M. S., Fuller, R. W. and Barnes, P. J. (1987). The effect of angiotensin converting enzyme inhibitor, ramipril on bronchial responses to inhaled histamine and brady-kinin in asthmatic subjects. Br. J. Clin. Pharmacol., 23, 91–3
Holgate, S. T., Burns, G. B., Robinson, C. and Church, M. K, (1984). Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2 and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J. Immunol., 133, 2138–44
MacDermot, J., Kelsey, C. R., Waddell, K. A., Richmond, R., Knight, R. K., Cole, P. J., Dollery, C. T., Landon, D. N. and Blair, I. A. (1982). Synthesis of leukotriene B4, and prostanoids by human alveolar macrophages: analysis by gas chromatography/mass spectrometry. Prostaglandins, 27, 163–79
Fels, A. O. S. and Cohn, Z. A. (1986). The alveolar macrophage. J. Appl. Physiol., 60, 353–69
Arnoux, B., Simoes Caeiro, M. H., Landes, A., Mathieu, M., Duroux, P. and Benveniste, J. (1982). Alveolar macrophages from asthmatic patients release platelet-activating factor (PAF-acether) and lyso-PAF-acether when stimulated with the specific allergen. Am. Rev. Resp. Dis., 125, 70
Borgeat, P. and Samuelsson, B. (1979). Arachidonic acid metabolism in polymorphonuclear leukocytes: Effects of ionophore A23187. Proc. Natl. Acad. Sci. USA, 76, 2148–52
Maurice, P. D. L., Bather, P. C. and Allen, B. R. (1986). Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis. Br. J. Dermatol., 114, 57–64
Venge, P., Hakansson, L. and Peterson, C. G. B. (1987). Eosinophil activation in allergic disease. Int. Arch. Allergy Appl. Immun., 82, 333–7
Schleimer, R. P., MacGlashan, D. W., Jr., Peters, S. P., Naclerio, R., Proud, D., Adkinson, N. F., Jr. and Lichtenstein, L. M. (1984). Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J. Allergy Clin. Immunol., 74, 473–81
Capron, A., Joseph, M., Ameisen, J. C., Capron, M., Pancre, V. and Auriault, C. (1987). Platelets as effectors in immune and hypersensitivity reactions. Int. Arch. Allergy Appl. Immun., 82, 307–12
Knauer, K. A., Lichtenstein, L. M., Adkinson, N. F., Jr. and Fish, J. E. (1981). Platelet activation during antigen-induced airway reactions in asthmatic subjects. N. Engl. J. Med., 304, 1404–7
Morley, J., Sanjar, S. and Page, C. P. (1984). The platelet in asthma. Lancet, 2, 1142–4
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Fuller, R.W. (1988). Target Tissues for Mediators in Human Allergic Reactions. In: Holgate, S.T. (eds) Mast Cells, Mediators and Disease. Immunology and Medicine Series, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1287-8_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-1287-8_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7072-0
Online ISBN: 978-94-009-1287-8
eBook Packages: Springer Book Archive